With 1.17 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.16 million shares. The 52-week range on TRMD shows that it touched its highest point at $40.47 and its lowest point at $16.76 during that stretch. It currently has a 1-year price target of $24.27. With its current market cap of 1.69 billion, TRMD has annualized dividend of $5.86 while the current yield stands at 33.78%. Beta for the stock currently stands at 0.09.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TRMD was down-trending over the past week, with a drop of -7.76%, but this was down by -13.47% over a month. Three-month performance dropped to -17.14% while six-month performance fell -51.93%. The stock lost -48.67% in the past year, while it has lost -10.80% so far this year. A look at the trailing 12-month EPS for TRMD yields 7.74 with Next year EPS estimates of 3.62. For the next quarter, that number is 0.61. This implies an EPS growth rate of -11.02% for this year and -40.83% for next year.
Float and Shares Shorts:
At present, 95.20 million TRMD shares are outstanding with a float of 53.38 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TRMD since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $6.53045 being high and $5.80612 being low. For TRMD, this leads to a yearly average estimate of $6.11583. Based on analyst estimates, the high estimate for the next quarter is $0.72 and the low estimate is $0.72. The average estimate for the next quarter is thus $0.72.
Summary of Insider Activity:
Insiders traded TRMD stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.